CL2007003333A1 - PURIFIED HEMOCIANINE OBTAINED FROM F. LATIMARGINATA, F. CUMINGI OR F. MAXIMA; PURIFIED HEMOCIANINE SUBUNITY; USE OF HEMOCIANINE, ITS SUBUNITIES OR IMMUNOGENIC FRAGMENTS; AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH HEMOCIANINE OR ITS ITS - Google Patents

PURIFIED HEMOCIANINE OBTAINED FROM F. LATIMARGINATA, F. CUMINGI OR F. MAXIMA; PURIFIED HEMOCIANINE SUBUNITY; USE OF HEMOCIANINE, ITS SUBUNITIES OR IMMUNOGENIC FRAGMENTS; AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH HEMOCIANINE OR ITS ITS

Info

Publication number
CL2007003333A1
CL2007003333A1 CL2007003333A CL2007003333A CL2007003333A1 CL 2007003333 A1 CL2007003333 A1 CL 2007003333A1 CL 2007003333 A CL2007003333 A CL 2007003333A CL 2007003333 A CL2007003333 A CL 2007003333A CL 2007003333 A1 CL2007003333 A1 CL 2007003333A1
Authority
CL
Chile
Prior art keywords
hemocianine
purified
latimarginata
subunities
cumingi
Prior art date
Application number
CL2007003333A
Other languages
Spanish (es)
Inventor
Maria Ines Becker
Original Assignee
Biosonda S A 70 Y Fundacion Ci
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biosonda S A 70 Y Fundacion Ci filed Critical Biosonda S A 70 Y Fundacion Ci
Priority to CL2007003333A priority Critical patent/CL2007003333A1/en
Publication of CL2007003333A1 publication Critical patent/CL2007003333A1/en

Links

CL2007003333A 2007-11-21 2007-11-21 PURIFIED HEMOCIANINE OBTAINED FROM F. LATIMARGINATA, F. CUMINGI OR F. MAXIMA; PURIFIED HEMOCIANINE SUBUNITY; USE OF HEMOCIANINE, ITS SUBUNITIES OR IMMUNOGENIC FRAGMENTS; AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH HEMOCIANINE OR ITS ITS CL2007003333A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2007003333A CL2007003333A1 (en) 2007-11-21 2007-11-21 PURIFIED HEMOCIANINE OBTAINED FROM F. LATIMARGINATA, F. CUMINGI OR F. MAXIMA; PURIFIED HEMOCIANINE SUBUNITY; USE OF HEMOCIANINE, ITS SUBUNITIES OR IMMUNOGENIC FRAGMENTS; AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH HEMOCIANINE OR ITS ITS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2007003333A CL2007003333A1 (en) 2007-11-21 2007-11-21 PURIFIED HEMOCIANINE OBTAINED FROM F. LATIMARGINATA, F. CUMINGI OR F. MAXIMA; PURIFIED HEMOCIANINE SUBUNITY; USE OF HEMOCIANINE, ITS SUBUNITIES OR IMMUNOGENIC FRAGMENTS; AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH HEMOCIANINE OR ITS ITS

Publications (1)

Publication Number Publication Date
CL2007003333A1 true CL2007003333A1 (en) 2008-04-04

Family

ID=40261571

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2007003333A CL2007003333A1 (en) 2007-11-21 2007-11-21 PURIFIED HEMOCIANINE OBTAINED FROM F. LATIMARGINATA, F. CUMINGI OR F. MAXIMA; PURIFIED HEMOCIANINE SUBUNITY; USE OF HEMOCIANINE, ITS SUBUNITIES OR IMMUNOGENIC FRAGMENTS; AND PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH HEMOCIANINE OR ITS ITS

Country Status (1)

Country Link
CL (1) CL2007003333A1 (en)

Similar Documents

Publication Publication Date Title
BRPI0814593A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
BRPI0818804A2 (en) Pyrimidine derivative compound, pharmaceutical composition comprising it and use of such compound.
NI201000055A (en) 2 '- FLUORO - 2' - DEOXYTETHYDROURIDINES AS INHIBITORS OF CITIDINE DESAMINE.
CL2011000527A1 (en) Compounds derived from benzofuran; pharmaceutical composition that includes them; and their use in the treatment of hepatitis c.
CL2011002787A1 (en) Substituted 1-cyanoethylheterocyclylcarboxamide derivative compounds, dipeptidylpeptidase i (dppi) or cathepsin c inhibitors; pharmaceutical composition; pharmaceutical combination; and its use in the treatment of asthma, chronic obstructive disease or allergic rhinitis.
BRPI0813341A2 (en) "USE OF COMPOUNDS, CURABLE COMPOSITIONS, AND, USE OF CURABLE COMPOSITIONS".
CL2007003423A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED PYRIMIDINS; PROCESS FOR THE PREPARATION OF SUCH COMPOUNDS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF Rheumatoid ARTHRITIS, ATEROSCLEROSIS, AMONG OTHER DISEASES
CL2007002916A1 (en) COMPOUNDS DERIVED FROM PIRAZOLILTIENOPIRIDINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE INHIBITION OF ESCARAS.
DK2207775T3 (en) 4-Benzylamino-1-carboxyacylpiperidine derivatives as CETP inhibitors useful in the treatment of diseases such as hyperlipidemia or arteriosclerosis
ECSP099027A (en) ANTI-DLL4 ANTIBODIES AND METHODS THAT USE THEM
CL2007002649A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES 2- [6- (3-AMINO-PIPERIDIN-1-IL) -3-METIL-2,4-DIOXO-3,4-DIHIDRO-2H-PIRIMIDIN-1-ILMETIL] -4-FLUORO- BENZONITRILE; AND USE FOR THE TREATMENT OF DIABETES.
CL2008002430A1 (en) Benzenesulfonamide derived compounds, cathepsin c inhibitors; pharmaceutical composition comprising them; and its use for the treatment of copd.
CL2008002295A1 (en) Alkylsulfonyl-substituted thiazolid derivative compounds; pharmaceutical composition; and use for the treatment of hepatitis c.
BRPI0815079A2 (en) 1,2-DIAMIDE-ETHYLENE DERICTED COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THIS COMPOUND
BRPI0917661A2 (en) product containing macitentan, pharmaceutical composition containing it and use of macitentan
BRPI1015043A2 (en) diazahomoadamantane derivatives and methods of use thereof
CR10229A (en) DERIVATIVES OF 1,2,4,5, -TETRAHIDRO-3H-BENZAZEPINAS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BRPI0717369A2 (en) COMPOUND, MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
CL2008000409A1 (en) COMPOUNDS DERIVED FROM 2- (4 AMINO-PIRROLO-PIRIDIN) FURAN-3,4 DIOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT AND / OR PREVENTION OF VIRAL INFECTIONS.
CL2007003232A1 (en) COMPOUNDS DERIVED FROM 5-HYDROXIMETHYL OXAZOLIDIN-2-ONA; PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS; AND ITS USE TO TREAT AND PREVENT BACTERIAL INFECTIONS.
CL2007001838A1 (en) COMPOUNDS DERIVED FROM 4-OXOQUINOLINE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND FOR THE PRODUCTION OF AN ANTI-HIV AGENT.
BRPI0810399A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USING THEREOF
CL2007003672A1 (en) COMPOUNDS DERIVED FROM HETEROARIL-PIRROLIDINIL-CETONA AND HETEROARIL-PIPERIDINIL-CETONA; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF DEPRESSION AND ANXIETY.
BRPI0720323A2 (en) compound, method of treatment, pharmaceutical composition and use of the compound
CL2008000463A1 (en) COMPOUNDS DERIVED FROM SUBSTITUTED BENZOFURANS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE TO TREAT PARASITARY INFECTIONS.